Two Repressor Genes Identified As Essential For Placental Development
The E2F family of genes is thought to play a crucial role in regulating cell proliferation.
It is unclear how these genes carry out their function and interact with one another in intact animals.
James Cancer Hospital to Offer Free Skin Cancer Screenings
COLUMBUS, Ohio – The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James) is offering free screenings for skin ca
Spielman Funds at James Cancer Hospital Top $10 Million
COLUMBUS, Ohio – What started as a quest by Chris and Stefanie Spielman to raise $250,000 for breast cancer research has been embraced by the central Ohio community – so much so – that mor
Study Suggests Current Definition of Circulating Tumor Cells Too Narrow; Finds New Characteristics of Double Positive Cells
COLUMBUS, Ohio – New research from The Ohio State University utilizes two different methods to visualize circulating tumor cells (CTCs) as well as other unusual circulating cells with both epithelia
Oncology Nursing Society Publication Edited By Ohio State Nurse Receives Award
COLUMBUS, Ohio – Research scientist Joanne Lester, who holds a doctorate of philosophy in nursing at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Ri
Dr. Mayr Inducted as Fellow of American Society for Radiation Oncology
COLUMBUS, Ohio – Dr. Nina A. Mayr, professor of radiation oncology at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research
Playing Football Was My Passion, But Fighting Cancer is My Purpose
Chris Spielman was a four-time Pro Bowl linebacker, Ohio State football legend, and perhaps the only high school student to appear on a Wheaties box. But he didn't tackle his toughest opponent until h
Cancer Cells Send Out The Alarm On Tumor-Killing Virus
Cancer-killing, or oncolytic, viruses show promise as therapy for brain tumors.
Clinical trials indicate that oncolytic virus therapy is safe but not as effective as expected in humans.
This study d
Blochs Commit $5 Million To Construction Of New James Cancer Hospital
COLUMBUS, Ohio – Janis and Michael Bloch of Bexley, Ohio, recently committed $5 million to the construction of the new Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, part of
Stefanie's Champions Luncheon Honors Cancer Caregivers
COLUMBUS, Ohio – The 13th annual Stefanie’s Champions Awards luncheon will honor five extraordinary heroes in the lives of cancer patients in the Archie M. Griffin Grand Ballroom at The Ohio Stat
Mini-Molecule Governs Severity Of Acute Graft-Vs-Host Disease, Study Finds
Graft-versus-host disease is a life-threatening problem for many bone-marrow transplant recipients.
New therapies are urgently needed to control the condition.
This study identifies a molecule that
Ohio State Surgeons Pioneer Removal Of Skull-Based Tumors Through the Nose and Mouth
COLUMBUS, Ohio – Surgeons at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC– James) Cranial Base Center have d
Tonsils Make T-Cells, Too, Ohio State Study Shows
T lymphocytes, or T cells, are essential for effective immune responses.
T cells were thought to be produced only in the thymus gland.
This study shows that T cells are also produced in the tonsils,
Dr. Chakravarti Inducted as Fellow of American College of Radiation Oncologists
COLUMBUS, Ohio – Dr. Arnab Chakravarti, chair and professor of Radiation Oncology, Max Morehouse Chair of Cancer Research, and co-director of the brain tumor program at the Ohio State University
James Cancer Experts to Compete in 'Top Doc' Cooking Challenge
COLUMBUS, Ohio – The first-ever “Top Doc” Cooking Challenge – an informational and entertaining food event similar to the popular TV shows “Top Chef” and “Chopped” – will feature four Ohio State
Mobile DNA Elements Can Disrupt Gene Expression And Cause Biological Variation, Study Shows
Numerous mouse strains show great biological variation in features such as behavior, coat color and susceptibility to cancer and other diseases.
This study examines one possible genetic cause fo
Oncolytic Virus Extends Survival In Medulloblastoma Model
Medulloblastoma is the most common malignant brain tumor in children.
Disseminated medulloblastoma is particularly lethal and requires extensive radiation therapy to the brain, which can cause bra
Understanding How Early Breast Tumors Become Deadly: A Small Group Of Molecules Might Hold The Answer
Some early-stage breast cancers are potentially harmless, but others invade surrounding healthy tissue and become deadly.
This study has identified a small pattern of molecules that highlights impo
Leaders From South Korea’s Cancer Center Travel To Ohio State To Learn Best Practices In Cancer Research And Care
COLUMBUS, Ohio – Leaders from Samsung Cancer Center, located in Seoul, South Korea, traveled 7,000 miles, flying for more than a day and crossing 14 hours in time zones, just to have the opportunity t
Oral HPV Infection is Three Times More Common in Men than Women, Study Shows
First author and study leader Dr. Maura Gillison, medical oncologist and head and neck cancer specialist at the OSUCCC – James, describes the findings of her paper, “Prevalence of Oral HPV Infect
Study Reveals Mechanism Of Lung-Cancer Drug Resistance
The most common form of lung cancer inevitably develops resistance to the targeted drug gefitinib.
This study shows how this resistance develops.
The findings suggest a new strategy for treating non
Dr. Caligiuri to Host 'Fireside Chat' About the Future of Cancer Research
COLUMBUS, Ohio – Michael A. Caligiuri, MD, director of The Ohio State University Comprehensive Cancer Center and CEO of the James Cancer Hospital and Solove Research Institute, will discuss the future
Anti-Sense Might Make Sense For Treating Liver Cancer
COLUMBUS, Ohio – A new study shows that it is possible to selectively target and block a particular microRNA that is important in liver cancer. The finding might offer a new therapy for this malignanc
Pelotonia To Fund 5 Postdoctoral Fellows At Ohio State
COLUMBUS, Ohio – The Pelotonia Fellowship Program, which is funded by the annual Pelotonia cycling event, will award grants to five postdoctoral students to conduct innovative cancer research at The
Ohio State Scientist Receives AMP Award For Excellence
COLUMBUS, Ohio – Dr. Carlo M. Croce, chair of the department of molecular virology, immunology, and medical genetics; and director of Human Cancer Genetics at Ohio State, received the Association for
Pelotonia To Fund Additional Cancer Research At Ohio State
COLUMBUS, Ohio – Six teams of scientists at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) are each
Hope Supports The New James Cancer Hospital And Solove Research Institute
COLUMBUS, Ohio – A 31-foot steel beam carrying messages of hope for a cancer-free world from nearly 1,000 James cancer survivors will be installed at 10:30 a.m. Thursday (12/22) at the new Arthur G
Study Reveals How Normal Cells Fuel Tumor Growth
· The study shows how normal cells in tumors can enhance the growth of the tumor’s cancer cells after losing an important tumor suppressor gene called Pten.
Scientists Discover Second-Oldest Gene Mutation
COLUMBUS, Ohio – A new study has identified a gene mutation that researchers estimate dates back to 11,600 B.C., making it the second oldest human disease mutation yet discovered.
Novel Export-Inhibitor Shows Promise For Treating CLL
COLUMBUS, Ohio – An experimental drug that works by blocking the export of key control molecules from the nucleus of cancer cells shows promise as a treatment for chronic lymphocytic leukemia (CLL)
Gene Mutation Signals A High Risk Of Recurrence In Some Older Acute-Leukemia Patients
COLUMBUS, Ohio – Older people with acute myeloid leukemia and normal looking chromosomes in their cancer cells have a higher risk of recurrence if they have mutations in a gene called ASXL1, accordi
Interim Study Shows Novel Experimental Agent is Highly Active in CLL Patients
COLUMBUS, Ohio – An interim analysis of a phase Ib/II clinical trial indicates that a novel experimental agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients w
Ohio State Researchers Discover Hereditary Predisposition to Melanoma of the Eye
Ohio – Ohio State University researchers have discovered a hereditary cancer syndrome
that predisposes certain people to a melanoma of the eye, along with lung
cancer, brain cancer and po
Third Time In Three Years, The James Earns Top Hospital Status
COLUMBUS, Ohio – For the third consecutive year and fourth time in five years, the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research I
Ohio State Studying How Chemotherapy Affects Breast Cancer Patients’ Hearts
COLUMBUS, Ohio – Ohio State University cancer and heart researchers are teaming up to find a better way to assess early cardiac injury from a class of chemotherapy drugs commonly used to treat breas
A New Study Suggests That A Neurotransmitter Might Improve The Treatment Of Cancer
COLUMBUS, Ohio – Doses of a neurotransmitter might offer a way to boost the effectiveness of anticancer drugs and radiation therapy, according to a new study led by researchers at the Ohio State Univ
Lower Antioxidant Level Might Explain Higher Skin-Cancer Rate In Males
COLUMBUS, Ohio – Men are three times more likely than women to develop a common form of skin cancer but medical science doesn’t know why. A new study may provide part of the answer.
Shapiro to Lead Breast Cancer Research Program at Ohio State
COLUMBUS, Ohio – Dr. Charles Shapiro has been named to lead the breast cancer research program at the
Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer
Hospital and Richard
Ohio State Cancer Expert Joins HemOnc Today Editorial Board
COLUMBUS, Ohio – Dr. Tanios Bekaii-Saab, medical director of gastrointestinal oncology at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove
NCI Funds Ohio State Breast Cancer Intervention Training
COLUMBUS, Ohio – Barbara Andersen, a professor of psychology and researcher at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research I
NCI Awards OSU Comprehensive Cancer Center $23 Million
Ohio – The Ohio State
University Comprehensive Cancer Center (OSUCCC) has received a 5-year, $23
million core grant renewal from the National
Cancer Institute (NCI) to support its broad
Pelotonia 11 Raises A Record $13.1 Million
COLUMBUS, Ohio -- Pelotonia has announced record fundraising of $13,108,639 for its 2011 ride. This year’s total reflects a 68% fundraising increase over the 2010 amount of $7,846,705.
Stefanie's Champions Seeks Nominations for Caregivers
COLUMBUS, Ohio – The 13th annual Stefanie’s Champions Awards is seeking nominations for caregivers who are helping improve the lives of cancer patients. Five Champions will be honored during an annua
Ohio State Cancer Expert Receives NCI Award For Team Leadership
COLUMBUS, Ohio – Dr. Tanios Bekaii-Saab, medical director of gastrointestinal oncology at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solo
Cancer Survivorship Research Reveals Disparities
COLUMBUS, Ohio –
Despite a general increase in research addressing cancer survivorship,
researchers have found that a disproportionate number of studies focus on
specific tumor sites, prevention,
New Oncolytic Virus Shows Improved Effectiveness In Preclinical Testing
COLUMBUS, Ohio – A new fourth-generation oncolytic virus designed to both kill cancer cells and inhibit blood-vessel growth has shown greater effectiveness than earlier versions when tested in animal
Internationally Renowned Oncologist Named Physician-In-Chief At Ohio State
COLUMBUS, Ohio – Internationally renowned gastrointestinal oncologist Dr. Richard M. Goldberg has been named physician-in-chief at The Ohio State University Comprehensive Cancer Center – Arthur G. Ja
Ohio State Cancer Researcher Wins 11th Consecutive Research Grant
COLUMBUS, Ohio – Ohio State University cancer researcher, Electra Paskett, has been awarded a grant from the Breast Cancer Research Foundation (BCRF) at the organization’s awards luncheon this week in
Ohio State Studies Whether Stress Affects HPV Vaccine Response
COLUMBUS, Ohio – Ohio State University cancer researchers are studying whether stress impacts how the body’s immune system responds to the human papillomavirus (HPV) vaccine.
The team of investigat
Ohio State Dedicates Comprehensive Breast Center in Honor of Stefanie Spielman
COLUMBUS, Ohio — The Ohio State University President E. Gordon Gee today announced the naming of The Stefanie Spielman Comprehensive Breast Center, in honor of the Ohio State alumna, philanthropist a